4D Molecular Therapeutics's total assets for Q4 2024 were $560.38M, a decrease of -7.23% from the previous quarter. FDMT total liabilities were $49.78M for the fiscal quarter, a -2.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.